Simon Quick Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.65M | Sell |
6,539
-204
| -3% | -$43.9K | 0.07% | 165 |
|
|
2026
Q1 | $1.47M | Sell |
6,743
-757
| -10% | -$168K | 0.07% | 166 |
|
|
2025
Q4 | $1.71M | Buy |
7,500
+373
| +5% | +$85K | 0.07% | 148 |
|
|
2025
Q3 | $1.65M | Buy |
7,127
+594
| +9% | +$121K | 0.07% | 154 |
|
|
2025
Q2 | $1.21M | Sell |
6,533
-15,172
| -70% | -$2.82M | 0.06% | 168 |
|
|
2025
Q1 | $4.55M | Buy |
21,705
+2,688
| +14% | +$523K | 0.26% | 45 |
|
|
2024
Q4 | $3.38M | Buy |
19,017
+8,238
| +76% | +$1.51M | 0.2% | 54 |
|
|
2024
Q3 | $2.13M | Buy |
10,779
+1,607
| +18% | +$300K | 0.13% | 80 |
|
|
2024
Q2 | $1.57M | Buy |
9,172
+1,540
| +20% | +$255K | 0.11% | 91 |
|
|
2024
Q1 | $1.39M | Buy |
7,632
+1,333
| +21% | +$230K | 0.1% | 98 |
|
|
2023
Q4 | $976K | Sell |
6,299
-503
| -7% | -$73.3K | 0.09% | 111 |
|
|
2023
Q3 | $1.01M | Buy |
6,802
+1,032
| +18% | +$152K | 0.1% | 106 |
|
|
2023
Q2 | $777K | Sell |
5,770
-1,195
| -17% | -$175K | 0.07% | 121 |
|
|
2023
Q1 | $1.11M | Buy |
6,965
+935
| +16% | +$143K | 0.12% | 90 |
|
|
2022
Q4 | $974K | Buy |
6,030
+1,717
| +40% | +$263K | 0.12% | 90 |
|
|
2022
Q3 | $579K | Buy |
4,313
+164
| +4% | +$23.5K | 0.08% | 111 |
|
|
2022
Q2 | $573K | Buy |
4,149
+1,277
| +44% | +$195K | 0.08% | 114 |
|
|
2022
Q1 | $466K | Sell |
2,872
-808
| -22% | -$117K | 0.13% | 67 |
|
|
2021
Q4 | $498K | Buy |
3,680
+344
| +10% | +$40.6K | 0.13% | 71 |
|
|
2021
Q3 | $359K | Buy |
3,336
+229
| +7% | +$26.2K | 0.09% | 89 |
|
|
2021
Q2 | $350K | Buy |
3,107
+45
| +1% | +$5.07K | 0.09% | 83 |
|
|
2021
Q1 | $331K | Buy |
3,062
+1,035
| +51% | +$111K | 0.1% | 77 |
|
|
2020
Q4 | $217K | Buy |
2,027
+1,405
| +226% | +$135K | 0.07% | 103 |
|
|
2020
Q3 | $54K | Sell |
622
-92
| -13% | -$8.66K | 0.02% | 181 |
|
|
2020
Q2 | $70K | Sell |
714
-120
| -14% | -$10.6K | 0.03% | 158 |
|
|
2020
Q1 | $64K | Buy |
834
+234
| +39% | +$19.9K | 0.02% | 165 |
|
|
2019
Q4 | $53K | Sell |
600
-25
| -4% | -$2.08K | 0.02% | 215 |
|
|
2019
Q3 | $47K | Buy |
625
+600
| +2,400% | +$41.1K | 0.02% | 180 |
|
|
2019
Q2 | $1.82K | Buy |
+25
| New | +$1.97K | ﹤0.01% | 369 |
|
|
2019
Q1 | – | Sell |
-693
| Closed | -$64K | – | 389 |
|
|
2018
Q4 | $64K | Buy |
+693
| New | +$60.9K | 0.02% | 160 |
|
|
2018
Q3 | – | Sell |
-93
| Closed | -$8K | – | 305 |
|
|
2018
Q2 | $8K | Buy |
+93
| New | +$9.08K | ﹤0.01% | 273 |
|
|
2018
Q1 | – | Sell |
-950
| Closed | -$107K | – | 305 |
|
|
2017
Q4 | $107K | Buy |
950
+300
| +46% | +$28.3K | 0.05% | 146 |
|
|
2017
Q3 | $58K | Hold |
650
| – | – | 0.02% | 248 |
|
|
2017
Q2 | $47K | Sell |
650
-777
| -54% | -$52.2K | 0.03% | 127 |
|
|
2017
Q1 | $93K | Sell |
1,427
-1,395
| -49% | -$87.7K | 0.06% | 119 |
|
|
2016
Q4 | $177K | Buy |
+2,822
| New | +$172K | 0.13% | 93 |
|
Other funds holding ABBV
Simon Quick Advisors's ABBV Position: Q2 2026 in Review
Simon Quick Advisors reduced its AbbVie (ABBV) stake by 3% in Q2 2026, selling an estimated $43.9K and leaving 6,539 shares worth $1.65M. The position accounts for 0.07% of the portfolio, ranked #165.
Simon Quick Advisors first reported a position in ABBV in Q4 2016 and has held it in 36 quarters since. The position peaked at $4.55M in Q1 2025. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Simon Quick Advisors held 6,539 shares of AbbVie worth $1.65M as of Q2 2026.
- Simon Quick Advisors sold 204 AbbVie shares in Q2 2026, an estimated $43.9K.
- AbbVie made up 0.07% of Simon Quick Advisors's portfolio in Q2 2026, its #165 holding.
- Simon Quick Advisors first reported a position in AbbVie in Q4 2016 and has held it in 36 quarters since.
- Simon Quick Advisors's AbbVie position peaked at $4.55M in Q1 2025.
- 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.